Our findings indicated that CYP1A1 exhibited higher A-to-I editing levels in 95D highly metastatic lung cancer cell compared with other cell lines (Fig. S1B), suggesting a potentially pivotal role of this A-to-I RNA edited site of CYP1A1 in cancer progression. The gene discussed is CYP1A1; the disease is lung cancer.